All tenders
75N95024F00007

OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number
75N95024F00007
Government level
Federal
Solicitation type
Other
Title
OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).
Source ID
usa-75N95024F00007

Details

Location
United States

Description

OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23). Awarded to: THE EMMES COMPANY, LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER

Dates

Publication
2024/08/15 12:00:00 AM UTC
Closing date
2028/03/31 12:00:00 AM UTC

Estimated value

$1.9M USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-09-02, 12:02:00 p.m.

Data refreshed every 2 hours